Introduction and concluding remarks

被引：67

作者：

Chapple, CR ^{[1
]}

机构：

[1] Royal Hallamshire Hosp, Dept Urol, Sheffield S10 2JF, S Yorkshire, England

来源：

EUROPEAN UROLOGY | 1999年 / 36卷

关键词：

benign prostatic hyperplasia; disease management; surgery; medical therapy; Europe; US;

D O I：

10.1159/000052342

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 6

页数：6

共 23 条

[1] Management of the BPH syndrome in Germany: Who is treated and how? [J].

Berges, RR ;

Pientka, L .

EUROPEAN UROLOGY, 1999, 36 :21-27

[2] THE INTERNATIONAL PROSTATE SYMPTOM SCORE IN A COMMUNITY-BASED SAMPLE OF MEN BETWEEN 55 AND 74 YEARS OF AGE - PREVALENCE AND CORRELATION OF SYMPTOMS WITH AGE, PROSTATE VOLUME, FLOW-RATE AND RESIDUAL URINE VOLUME [J].

BOSCH, JLHR ;

HOP, WCJ ;

KIRKELS, WJ ;

SCHRODER, FH .

BRITISH JOURNAL OF UROLOGY, 1995, 75 (05) :622-630

[3] Management of symptomatic BPH in the US: Who is treated and how? [J].

Bruskewitz, R .

EUROPEAN UROLOGY, 1999, 36 :7-13

[4]

Carraro JC, 1996, PROSTATE, V29, P231, DOI 10.1002/(SICI)1097-0045(199610)29:4&lt

[5]

231::AID-PROS4&gt

[6]

3.0.CO

[7]

2-E

[8] THE PREVALENCE OF PROSTATISM - A POPULATION-BASED SURVEY OF URINARY SYMPTOMS [J].

CHUTE, CG ;

PANSER, LA ;

GIRMAN, CJ ;

OESTERLING, JE ;

GUESS, HA ;

JACOBSEN, SJ ;

LIEBER, MM .

JOURNAL OF UROLOGY, 1993, 150 (01) :85-89

[9] α1-blockers for BPH:: Are there differences? [J].

de Mey, C .

EUROPEAN UROLOGY, 1999, 36 :52-63

[10] Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia [J].

Debruyne, FMJ ;

Jardin, A ;

Colloi, D ;

Resel, L ;

Witjes, WPJ ;

Delauche-Cavallier, MC ;

McCarthy, C ;

Geffriaud-Ricouard, C .

EUROPEAN UROLOGY, 1998, 34 (03) :169-175

← 1 2 3 →